Apiam Animal Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Apiam Animal Health şirketinin kazançları yıllık ortalama -0.01% oranında azalırken, Healthcare sektörünün kazançları yıllık 3.3% oranında azalan oldu. Gelirler yıllık ortalama 14.5% oranında artan oldu. Apiam Animal Health şirketinin öz sermaye getirisi 4% olup, net marjı 2.4% dir.

Anahtar bilgiler

-0.008%

Kazanç büyüme oranı

-10.5%

EPS büyüme oranı

Healthcare Sektör Büyümesi	2.4%
Gelir büyüme oranı	14.5%
Özkaynak getirisi	4.0%
Net Marj	2.4%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Apiam Animal Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

CHIA:AHX Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	205	5	0
31 Mar 24	204	4	0
31 Dec 23	202	3	0
30 Sep 23	197	2	0
30 Jun 23	192	2	0
31 Mar 23	184	4	0
31 Dec 22	176	6	0
30 Sep 22	166	5	0
30 Jun 22	157	5	0
31 Mar 22	149	4	0
31 Dec 21	140	4	1
30 Sep 21	133	5	1
30 Jun 21	126	5	2
31 Mar 21	125	5	2
31 Dec 20	123	5	2
30 Sep 20	121	5	2
30 Jun 20	118	4	2
31 Mar 20	115	4	2
31 Dec 19	112	3	2
30 Sep 19	112	3	2
30 Jun 19	112	3	2
31 Mar 19	112	3	2
31 Dec 18	112	3	2
30 Sep 18	109	3	2
30 Jun 18	107	3	2
31 Mar 18	105	3	1
31 Dec 17	103	4	1
30 Sep 17	100	4	1
30 Jun 17	98	5	1
31 Mar 17	94	5	2
31 Dec 16	90	5	2
30 Sep 16	72	3	2
30 Jun 16	54	0	1

Kaliteli Kazançlar: AHX yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: AHX 'nin mevcut net kar marjları (2.4%) geçen yılın (1.2%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: AHX şirketinin kazançları son 5 yılda yılda 0.01% oranında azaldı.

Büyüme Hızlandırma: AHX 'un son bir yıldaki kazanç büyümesi ( 116.6% ) 5 yıllık ortalamasını (yıllık -0.01% ) aşıyor.

Kazançlar vs. Sektör: AHX geçen yılki kazanç büyümesi ( 116.6% ) Healthcare sektörünün -25.4% değerini aştı.

Özkaynak Getirisi

Yüksek ROE: AHX 'nin Özsermaye Getirisi ( 4% ) düşük olarak değerlendiriliyor.

Apiam Animal Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings released: EPS: AU$0.028 (vs AU$0.013 in FY 2023)

Apiam Animal Health Limited to Report Fiscal Year 2024 Results on Aug 23, 2024

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Full year 2023 earnings released: EPS: AU$0.013 (vs AU$0.034 in FY 2022)

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Recent updates

Apiam Animal Health Limited, Annual General Meeting, Nov 21, 2024

An undisclosed buyer terminated the acquisition of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited Announces Board Changes

Full year 2024 earnings released: EPS: AU$0.028 (vs AU$0.013 in FY 2023)

Apiam Animal Health Limited to Report Fiscal Year 2024 Results on Aug 23, 2024

MD & Executive Director recently bought AU$596k worth of stock

Upcoming dividend of AU$0.01 per share

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

MD & Executive Director recently bought AU$134k worth of stock

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: AU$0.013 (vs AU$0.034 in FY 2022)

New minor risk - Financial data availability

New minor risk - Share price stability

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Apiam Animal Health Limited (ASX:AHX) acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harradine and Associates for AUD 2.6 million.

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Full year 2022 earnings released: EPS: AU$0.034 (vs AU$0.042 in FY 2021)

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Apiam Animal Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Insufficient new directors

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire assets of Victorian Equine Group and Romsey Veterinary Surgery for AUD 13.75 million.

Insufficient new directors

Upcoming dividend of AU$0.012 per share

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Period Ended December 31, 2021, Payable on April 20, 2022

Apiam Animal Health Limited to Report First Half, 2022 Results on Feb 25, 2022

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Fraser Coast Veterinary Services.

MD & Executive Director recently bought AU$96k worth of stock

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Harbour City Veterinary Surgery.

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.042 (vs AU$0.037 in FY 2020)

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harbour City Veterinary Surgery for AUD 2.8 million.

Apiam Animal Health Limited (ASX: AHX) acquired Assets of Golden Plains Animal Hospital.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire The Scenic Rim for AUD 16 million.

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Samford Valley Veterinary Hospital.

Apiam Animal Health Limited (ASX:AHX) acquired Clermont Veterinary Surgery.

MD & Executive Director recently bought AU$252k worth of stock

Upcoming Dividend of AU$0.012 Per Share

Apiam Animal Health Limited to Report First Half, 2021 Results on Feb 24, 2021

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Crosvet Pty Ltd.

Apiam Animal Health Limited Announces Executive Changes, Effective November 30, 2020

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Crosvet Pty Ltd for AUD 5 million.

New 90-day high: AU$0.66

New 90-day high - AU$0.61

Upcoming Dividend of AU$0.012 Per Share

Full year earnings released - EPS AU$0.037

New 90-day high - AU$0.51

Apiam Animal Health Limited (ASX:AHX) acquired Devoted Vets at Warragul Vic for AUD 0.5 million.

Apiam Animal Health Limited to Report Fiscal Year 2020 Results on Aug 24, 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin